Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E I Walter

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1990
The influence of membrane components on regulation of alternative pathway activation by decay-accelerating factorC Mold, E I Walter, M E Medof
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1988
Association of cytoskeletal re-organization with capping of the complement decay-accelerating factor on T lymphocytesG M Kammer, E I Walter, M E Medof
Biochemistry|November 4, 1986
Decay accelerating factor of complement is anchored to cells by a C-terminal glycolipidM E Medof, E I Walter, W L Roberts, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|February 1, 1996
Stepwise transformation of astrocytes by simian virus 40 large T antigen and epidermal growth factor receptor overexpressionP S Frisa, E I Walter, L Ling, et al.
The Journal of Experimental Medicine|March 1, 1987
Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluidsM E Medof, E I Walter, J L Rutgers, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1990
Structural basis for variations in the sensitivity of human decay accelerating factor to phosphatidylinositol-specific phospholipase C cleavageE I Walter, W L Roberts, T L Rosenberry, et al.
The Journal of Biological Chemistry|January 15, 1992
Effect of glycoinositolphospholipid anchor lipid groups on functional properties of decay-accelerating factor protein in cellsE I Walter, W D Ratnoff, K E Long, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1989
Heightened complement sensitivity of acquired immunodeficiency syndrome lymphocytes related to diminished expression of decay-accelerating factorM M Lederman, S F Purvis, E I Walter, et al.
The Journal of Clinical Investigation|April 1, 1988
Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitroN K Cheung, E I Walter, W H Smith-Mensah, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 1998
Mammalian glycophosphatidylinositol anchor transfer to proteins and posttransfer deacylationR Chen, E I Walter, G Parker, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1990
The influence of membrane components on regulation of alternative pathway activation by decay-accelerating factorC Mold, E I Walter, M E Medof
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1988
Association of cytoskeletal re-organization with capping of the complement decay-accelerating factor on T lymphocytesG M Kammer, E I Walter, M E Medof
Biochemistry|November 4, 1986
Decay accelerating factor of complement is anchored to cells by a C-terminal glycolipidM E Medof, E I Walter, W L Roberts, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|February 1, 1996
Stepwise transformation of astrocytes by simian virus 40 large T antigen and epidermal growth factor receptor overexpressionP S Frisa, E I Walter, L Ling, et al.
The Journal of Experimental Medicine|March 1, 1987
Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluidsM E Medof, E I Walter, J L Rutgers, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1990
Structural basis for variations in the sensitivity of human decay accelerating factor to phosphatidylinositol-specific phospholipase C cleavageE I Walter, W L Roberts, T L Rosenberry, et al.
The Journal of Biological Chemistry|January 15, 1992
Effect of glycoinositolphospholipid anchor lipid groups on functional properties of decay-accelerating factor protein in cellsE I Walter, W D Ratnoff, K E Long, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1989
Heightened complement sensitivity of acquired immunodeficiency syndrome lymphocytes related to diminished expression of decay-accelerating factorM M Lederman, S F Purvis, E I Walter, et al.
The Journal of Clinical Investigation|April 1, 1988
Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitroN K Cheung, E I Walter, W H Smith-Mensah, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 1998
Mammalian glycophosphatidylinositol anchor transfer to proteins and posttransfer deacylationR Chen, E I Walter, G Parker, et al.
Pageof 2